PKZ-15699-17075
2 vaccinations
1 coded response
2 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 331 / FL
- Registered
- 2021-01-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-16
Dose 1 — Pfizer-BioNTech
-
2021-01-06
Registered in v-safe
-
2021-01-06
Dose 2 — Pfizer-BioNTech
-
2021-01-06
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2021-07-12
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: Pregnant with aneuploid pregnancy (trisomy 21). LMP 2/3/21. Last dose of vaccine 1/6/21MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-06 | Pfizer-BioNTech |
Free text
Release 9 — 6 months, dose 2
Symptoms: Pregnant with aneuploid pregnancy (trisomy 21). LMP 2/3/21. Last dose of vaccine 1/6/21
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release